Nov. 7, 2023
by Bohdana Sokolova
Biopharma insight
In the ongoing pursuit of new drugs and medical treatments, the pharmaceutical sector faces a complex task: verifying the safety …
Nov. 7, 2023
by Tim Sandle
Biopharma insight
The digital transformation of biopharmaceutical manufacturing has continued at a rapid pace as companies mine the rich sources of data …
Nov. 3, 2023
by Andrii Buvailo
Biopharma insight
The first biologics drug, humanized insulin (5.8 kDa), became available in 1982 following the advent of biotechnology, and it marked …
Oct. 20, 2023
by Andrii Buvailo
Biopharma insight
It is hard to overestimate the potential of biotechnology to address some of the most pressing challenges of the 21st …
Oct. 20, 2023
by Andrii Buvailo
Biopharma insight
‘Garbage in, garbage out’ is a well-known principle in the machine learning (ML) community, and it is certainly true when …
Oct. 6, 2023
by Andrii Buvailo
Biopharma insight
From gene editing and artificial intelligence (AI)-driven protein design, to cutting-edge 3D bioprinting, tissue engineering and microfluidics – Lithuania appears …
Aug. 16, 2023
by Anthony Platt
Biopharma insight
The UK’s health technology market has seen unprecedented levels of M&A transactions and fundraising. The Covid-19 pandemic acted as a …
Aug. 1, 2023
by Andrii Buvailo
Biopharma insight
As the global pharmaceutical landscape continues to transform at a breathtaking pace, it becomes crucial to examine the phenomenon that …
July 26, 2023
by Andrii Buvailo
Biopharma insight
AI in Drug Discovery at a Glance The ongoing rise of artificial intelligence (AI) is significantly impacting various industries, with …
July 14, 2023
by Andrii Buvailo
Biopharma insight
Since the early days of the pharmaceutical industry, small molecules have been the most extensively used group of drugs. Nowadays, …
July 11, 2023
by Andrii Buvailo
Biopharma insight
(Last updated: July 2023) Pharmaceutical companies are increasingly outsourcing research activities to academic institutions, tech-driven companies, and private contract research …
July 6, 2023
by Andrii Buvailo
Biopharma insight
(Last updated: July 2023) The type of artificial intelligence (AI) which scares business leaders, experts, and activists all over the …